36TH GENERAL MEETING OF ERIC MEMBERS AT THE 56TH ASH CONGRESS

7 DECEMBER 2014, SAN FRANCISCO (UNITED STATES OF AMERICA)

  • Agenda
  • MRD and diagnostic panel harmonisation (A. Rawstron)
  • ERIC Project: Harmonization of TP53 Mutation Testing (E. Tausch)
  • Recurrent mutation project within ERIC – report from the harmonization and gene panel activities (A. Hadzidmitriou / L. Sutton)
  • Randomized controlled trial to study the value of allogeneic stem cell transplantation in the era of ibrutinib therapy in high risk CLL (M. van Gelder)

35TH GENERAL MEETING OF ERIC MEMBERS AT THE 19TH EHA CONGRESS

12 JUNE 2014, MILAN (ITALY)

  • Agenda
  • The MRD Harmonisation Approach by Flow Cytometry (A. Rawstron)
  • Recurrent gene mutations in CLL – harmonization and future directions- Presentation paper (R. Rosenquist

JOINT EHA / ERIC SYMPOSIUM: CELLULAR ORIGIN AND IMMUNE SYSTEM IN CLL

  • Agenda
  • Cellular Origin of CLL (R. Küppers)
  • The Clinical Implications of Understanding Immune Deficiency and Autoimmune Phenomena in CLL (C. Moreno)
  • Harnessing the Immune System to Treat (Cure?) CLL (A. Ramsay)
  • The Innate Immune System in CLL – Focus on Monocytes/Macrophages (M. Seiffert)

34TH GENERAL MEETING OF ERIC MEMBERS AT THE 11TH ANNUAL SYMPOSIUM OF THE ELN

4 FEBRUARY 2014, CONGRESS CENTRE ROSENGARTEN, MANNHEIM (GERMANY)

  • Agenda
  • PDF presentation ERIC MRD ELN Mannheim